Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?
about
Sulodexide and glycosaminoglycans in the progression of renal diseaseThe Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression.The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.Peroxisome proliferator activating receptor-γ and the podocyte.Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse.Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients.Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes.Preclinical and Clinical Effects of RAS Inhibition with a Focus on Telmisartan
P2860
Q26991825-AB5A6080-914E-4C71-81C2-7BCC1F13B783Q36182961-267A9FE8-E0A5-4F9C-B568-743E0159F74BQ36912517-F848B869-51BD-4E61-A33E-19029E317D50Q37980260-9BE93231-3B54-4C84-A881-F8FDF4842C08Q38019761-721D3EF4-AABC-4720-A147-EF1FCB6F70E7Q38674739-2A61602E-6AEA-4D9E-A8E2-2F3D07EA38F0Q38815188-31E895C3-1E7D-40E3-8712-343E9DB8BF6FQ43088280-1B673719-BEF1-4EB1-BD4E-A320B01C8415Q44945294-81994AB2-495B-456C-9471-97B145928858Q47147374-ACCDC983-AAA3-494E-BC81-31EDC9EF1603Q51386085-6E64BFDC-D2F0-4B07-BA49-A2B520FABB0FQ54001331-DE6807EC-A751-4823-B18B-3535F05D491DQ58691749-FB66C2BF-D9C9-4C2A-961F-4EF3020D6A28
P2860
Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Metabolic actions of angiotens ...... ist actions or a class effect?
@ast
Metabolic actions of angiotens ...... ist actions or a class effect?
@en
type
label
Metabolic actions of angiotens ...... ist actions or a class effect?
@ast
Metabolic actions of angiotens ...... ist actions or a class effect?
@en
prefLabel
Metabolic actions of angiotens ...... ist actions or a class effect?
@ast
Metabolic actions of angiotens ...... ist actions or a class effect?
@en
P2860
P1476
Metabolic actions of angiotens ...... ist actions or a class effect?
@en
P2093
Richard J Koletsky
P2860
P304
P356
10.1016/J.COPH.2006.11.008
P577
2007-02-15T00:00:00Z